IRF2BP2

Interferon regulatory factor 2-binding protein 2 · Q7Z5L9 · IRF2BP2 on Sugi Atlas →

0 patent compounds predicted against IRF2BP2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to IRF2BP2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Clinical Evaluation of the Effect of Metformin in Sepsis PHASE3UNKNOWN
Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized) PHASE3UNKNOWN
Pirfenidone LP or Collagen-polyvinylpyrrolidone in COVID-19 PHASE2/PHASE3COMPLETED
Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19 PHASE2UNKNOWN
A Study Testing Emactinib Sulfate With Chemotherapy and Immunotherapy Before Surgery for Advanced Head and Neck Cancer PHASE2RECRUITING
The High-Dose Aldesleukin (IL-2) Select Trial for Patients With Metastatic Renal Cell Carcinoma PHASE2COMPLETED
Polyinosinic-Polycytidylic Acid-poly-L-lysine Carboxymethylcellulose (Poly-ICLC) in Healthy Volunteers PHASE1COMPLETED
sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS PHASE1COMPLETED
Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein PHASE1COMPLETED
Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP) PHASE1UNKNOWN
S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Recombinant Interferon Alfa-2b in Treating Patients With Melanoma nanCOMPLETED
Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts nanCOMPLETED
ADAR1 Expression Level in Rectal Cancer nanRECRUITING
Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis nanCOMPLETED
Prediction of Response to Treatment of Patients With Chronic HCV Infection by Genetic Profile nanUNKNOWN
Gene Expression Profiling in Type 1 Diabetes nanCOMPLETED
Hepatitis C in Clinically Discordant Hemophilic Siblings nanCOMPLETED
Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Nasal Immune Challenge Study nanUNKNOWN
Study of Leukocyte Populations in Patients With Chronic Inflammatory nanUNKNOWN
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis Patient nanRECRUITING
Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus nanCOMPLETED
Immune Signature of Palmoplantar Pustulosis nanCOMPLETED
NCF Gene & TNFSF4 in SLE Patients nanUNKNOWN
Interferon Pathway Activation in Monogenic and Nonmonogenic Forms of Pediatric SLE nanRECRUITING
STAT4 in Multiple Sclerosis by PCR and Flow Cytometry nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a IRF2BP2 binder may also engage these)

ProteinNameSimilarity
E9Q1P8 1.000 E9Q1P8 →
Q8K3X4 0.998 Q8K3X4 →
Q5EIC4 0.997 Q5EIC4 →
Q9H1B7 0.996 Q9H1B7 →
Q7T2G1 0.995 Q7T2G1 →
Q2MJS2 0.994 Q2MJS2 →
Q8IU81 0.991 Q8IU81 →
Q6PCG7 0.989 Q6PCG7 →
Q66IY8 0.989 Q66IY8 →
Q8R3Y8 0.988 Q8R3Y8 →
Q6DIH5 0.988 Q6DIH5 →
Q7ZXS3 0.987 Q7ZXS3 →
Q61127 0.986 Q61127 →
O35615 0.986 O35615 →
Q6NZT6 0.985 Q6NZT6 →
A7XYQ1 0.985 A7XYQ1 →
Q1LV17 0.985 Q1LV17 →
A7XYH9 0.984 A7XYH9 →
Q863A2 0.984 Q863A2 →
Q14135 0.984 Q14135 →
O95936 0.984 O95936 →
Q8C3Q5 0.984 Q8C3Q5 →
Q0P5V2 0.984 Q0P5V2 →
A2A9A2 0.984 A2A9A2 →
O43439 0.983 O43439 →
Q96PX6 0.983 Q96PX6 →
P49715 0.983 P49715 →
Q13207 0.983 Q13207 →
Q9ERQ3 0.983 Q9ERQ3 →
O14529 0.983 O14529 →